Clinical Trial Update: GABAergic Modulation in Pain Transmission in Human: Effect of the GABAA Agonist Clobazam on Peripheral and Central Sensitisation [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial investigated clobazam, a GABAA agonist, for neuropathic pain to assess effects on peripheral and central sensitisation; the study has…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuropathic Pain

Drugs mentioned

• CLOBAZAM (CLOBAZAM)

Snippet

Sponsor: University Hospital, Geneva | Conditions: Neuropathic Pain | Phase 1, Phase 2 | Status: COMPLETED